Search - tctmd.com

Displaying 201 - 220 of 482

Sort: Relevancy | Date

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

News Daily News

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

L.A. McKeown

June 16, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Todd Neale

January 29, 2020

News Daily News

Societies Propose Volume, Proficiency Needs for Mitral Interventions

Todd Neale

December 17, 2019

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

Advertisement

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Device Explants After TAVR Rare but Risky

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Societies Propose Volume, Proficiency Needs for Mitral Interventions

Routine Anticoagulation Seems Warranted After TMVR: Review

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content